253 related articles for article (PubMed ID: 22348399)
1. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
Trials; 2012 Feb; 13():18. PubMed ID: 22348399
[TBL] [Abstract][Full Text] [Related]
2. Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population.
von Wagner C; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Macleod U; Duffy S
BMJ Open; 2018 May; 8(5):e022263. PubMed ID: 29730633
[TBL] [Abstract][Full Text] [Related]
3. GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.
Benton SC; Butler P; Allen K; Chesters M; Rickard S; Stanley S; Roope R; Vulkan D; Duffy SW
Br J Cancer; 2017 Jun; 116(12):1551-1557. PubMed ID: 28524157
[TBL] [Abstract][Full Text] [Related]
4. The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
Wood A; Emery JD; Jenkins M; Chondros P; Campbell T; Wenkart E; O'Reilly C; Cowie T; Dixon I; Toner J; Khalajzadeh H; Gutierrez JM; Govan L; Buckle G; McIntosh JG
Trials; 2022 Jan; 23(1):31. PubMed ID: 35022080
[TBL] [Abstract][Full Text] [Related]
5. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.
Hewitson P; Ward AM; Heneghan C; Halloran SP; Mant D
Br J Cancer; 2011 Aug; 105(4):475-80. PubMed ID: 21829202
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
Trials; 2013 Jul; 14():239. PubMed ID: 23902589
[TBL] [Abstract][Full Text] [Related]
7. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial.
Dodd N; Carey M; Mansfield E; Oldmeadow C; Evans TJ
Aust N Z J Public Health; 2019 Oct; 43(5):464-469. PubMed ID: 31268211
[TBL] [Abstract][Full Text] [Related]
8. Using primary care-based paper and telephone interventions to increase uptake of bowel scope screening in Yorkshire: a protocol of a randomised controlled trial.
McGregor LM; Kerrison RS; Green T; Macleod U; Hughes M; Gibbins M; Morris S; Rees C; von Wagner C
BMJ Open; 2018 Jul; 8(7):e024616. PubMed ID: 30056395
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
Damery S; Clifford S; Wilson S
BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
[TBL] [Abstract][Full Text] [Related]
10. Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study).
Sali L; Grazzini G; Carozzi F; Castiglione G; Falchini M; Mallardi B; Mantellini P; Ventura L; Regge D; Zappa M; Mascalchi M; Milani S
Trials; 2013 Mar; 14():74. PubMed ID: 23497601
[TBL] [Abstract][Full Text] [Related]
11. Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.
Raine R; Duffy SW; Wardle J; Solmi F; Morris S; Howe R; Kralj-Hans I; Snowball J; Counsell N; Moss S; Hackshaw A; von Wagner C; Vart G; McGregor LM; Smith SG; Halloran S; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Atkin W
Br J Cancer; 2016 Feb; 114(3):321-6. PubMed ID: 26742011
[TBL] [Abstract][Full Text] [Related]
12. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.
Wardle J; von Wagner C; Kralj-Hans I; Halloran SP; Smith SG; McGregor LM; Vart G; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Counsell N; Morris S; Duffy SW; Hackshaw A; Moss S; Atkin W; Raine R
Lancet; 2016 Feb; 387(10020):751-9. PubMed ID: 26680217
[TBL] [Abstract][Full Text] [Related]
13. Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial.
Hirst Y; Kerrison R; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
BMC Public Health; 2016 Jan; 16():74. PubMed ID: 26809344
[TBL] [Abstract][Full Text] [Related]
14. Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.
Regge D; Iussich G; Senore C; Correale L; Hassan C; Bert A; Montemezzi S; Segnan N
Trials; 2014 Mar; 15():97. PubMed ID: 24678896
[TBL] [Abstract][Full Text] [Related]
15. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.
Blanks RG; Benson VS; Alison R; Brown A; Reeves GK; Beral V; Patnick J; Green J
Br J Cancer; 2015 Apr; 112(9):1562-7. PubMed ID: 25742470
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening practise is influenced by ethnicity of medical practitioner and patient.
Koo JH; You MY; Liu K; Athureliya MD; Tang CW; Redmond DM; Connor SJ; Leong RW
J Gastroenterol Hepatol; 2012 Feb; 27(2):390-6. PubMed ID: 21793910
[TBL] [Abstract][Full Text] [Related]
17. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
18. Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population.
Kaushal A; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Duffy S; von Wagner C
Prev Med; 2020 Dec; 141():106268. PubMed ID: 33022321
[TBL] [Abstract][Full Text] [Related]
19. General practitioners' perceptions of population based bowel screening and their influence on practice: a qualitative study.
Dawson G; Crane M; Lyons C; Burnham A; Bowman T; Perez D; Travaglia J
BMC Fam Pract; 2017 Mar; 18(1):36. PubMed ID: 28298185
[TBL] [Abstract][Full Text] [Related]
20. Use of research questionnaires in the NHS Bowel Cancer Screening Programme in England: impact on screening uptake.
Watson J; Shaw K; Macgregor M; Smith S; Halloran S; Patnick J; Beral V; Green J;
J Med Screen; 2013 Dec; 20(4):192-7. PubMed ID: 24177175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
